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Gadoxetic acid-enhanced magnetic resonance imaging has become a useful tool for quantitative 
evaluation of liver capacity. We report on the importance of intrahepatic fat on gadoxetic acid-
supported T1 mapping for estimation of liver maximum capacity, assessed by the realtime 
13C-methacetin breathing test (13C-MBT). For T1 relaxometry, we used a respective T1-weighted 
sequence with two-point Dixon water-fat separation and various flip angles. Both T1 maps of the in-
phase component without fat separation (T1_in) and T1 maps merely based on the water component 
(T1_W) were generated, and respective reduction rates of the T1 relaxation time (rrT1) were evaluated. 
A steady considerable decline in rrT1 with progressive reduction of liver function could be observed 
for both T1_in and T1_W (p < 0.001). When patients were subdivided into 3 different categories of 
13C-MBT readouts, the groups could be significantly differentiated by their rrT1_in and rrT1_W values 
(p < 0.005). In a simple correlation model of 13C-MBT values with T1_inpost (r = 0.556; p < 0.001), 
T1_Wpost (r = 0.557; p < 0.001), rrT1_in (r = 0.711; p < 0.001) and rrT1_W (r = 0.751; p < 0.001), a log-
linear correlation has been shown. Liver maximum capacity measured with 13C-MBT can be determined 
more precisely from gadoxetic acid-supported T1 mapping when intrahepatic fat is taken into account. 
Here, T1_W maps are shown to be significantly superior to T1_in maps without separation of fat.
For evaluation of liver function, medical professionals rely on a variety of diagnostic tools. A conservative method 
for evaluating liver function is the analysis of blood samples for hepatocytic transported organic anions (e.g., 
serum bilirubin), for serum enzymes detectable when the liver is injured (e.g., aminotransferases, alkaline phos-
phatase) or for liver’s biosynthetic capacity marker (e.g., serum proteins, albumin)1.
In recent years, the magnetic-resonance imaging (MRI), hepatocyte specific contrast agent gadoxetic acid 
(Gd-EOB-DTPA) has gained in importance, because T1 relaxometry supported by Gd-EOB-DTPA has proven 
to be a promising diagnostic method for assessing liver function or chronic hepatic diseases, in accordance 
with various clinical scoring systems (Child-Pugh score, MELD score), liver fibrosis scores (METAVIR score, 
ISHAK score), the ICG clearance test2–7 and only recently by our group with the 13C-methacetin breath test 
(13C-MBT)8. Gadoxetic acid is preferably imported into liver cells by respective ATP-dependent transporters 
(OATP1 B1/B3) during accumulation phase and excreted in the biliary system via multidrug resistance protein 
2 (MRP2)9,10. Due to the paramagnetic properties of gadolinium, accumulation and increasing concentration of 
Gd-EOB-DTPA shortens T1 and to a lesser extent the T2 relaxation time, particularly that of water molecules 
and protons, allowing for the quantitative evaluation of liver function6,11. To allow for a “one-stop-shot” and in 
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addition to conventional MRI-based information, such as the structure of liver parenchyma, liver vasculatures, 
liver lesions and their relation to vasculatures, gadoxetic acid-supported T1 mapping thus offers the potential 
to display imaging-based liver function. While established liver function tests such as the ICG-test or 13C-MBT, 
which enables evaluation of maximal liver function capacity (LiMax®) in real time12,13, only reflect global liver 
function, MRI-based assessment of liver function has the potential to illustrate both global and segmental level 
liver function.
In general, MRI signals in the human body are caused by hydrogen protons of water, triglycerides and fatty 
acids14. However, due to their characteristic chemical structure and properties, fatty acids exhibit a relatively 
short T1 relaxation time15; similarly, Gd-EOB-DTPA shortens the T1 relaxation time in interacting molecules. 
Therefore, in Gd-EOB-DTPA-supported T1 mapping, it still remains unclear to what extent the reduction of T1 
relaxation time is induced by the presence of intrahepatic fat. It might therefore be assumed that the reduction 
rate and thus liver function are overestimated in patients suffering from non-alcoholic steatohepatitis (NASH) 
or fatty liver disease, as the T1 relaxation time is expected to decrease with increasing fat fraction and the relative 
voxel-specific uptake of contrast agent is diminished when intrahepatic fat is present.
In clinical practice, it is common to apply fat-suppression methods for diagnostic imaging to both 
improve visualization of pathology and enhance contrast. The Dixon method is an established tool for obtain-
ing fat-suppressed water-only images or water-suppressed fat-only images16–18. In contrast to fat suppression 
by spectrally selective radiofrequency pulses, two contrasts at different echo times – typically in-phase and 
opposed-phase – are acquired, from which water and fat images can be calculated by a dedicated algorithm. This 
approach also has the advantage that the steady-state signal in a gradient echo sequence is not interrupted and all 
contrast including the derived water and fat images can be used for variable flip angle T1 mapping.
The purpose of this study was to compare in-phase, non-fat-suppressed T1 maps (T1_in) and water-only 
fat-suppressed T1 maps (T1_W) to evaluate the effect of intrahepatic fat on the MRI-based estimation of liver 
function.
Results
Patient characteristics. A total of 79 patients (62 men and 17 women; mean age, 61.85 years; range, 39–82 
years) were included in this study. All patients underwent a 13C-methacetin breath test (13C-MBT) within a time-
frame of 24 h to a T1-weighted VIBE sequence with variable flip angles and Dixon water-fat separation. The 
13C-MBT readout-dependent groups showed no significant difference in age, height and weight from each other, 
except for group 1, which was significantly shorter in height and lighter than groups 2 and 3 (p < 0.05; Table 1). 
Patients with a good 13C-MBT readout value also showed stronger contrast agent uptake during the hepatobiliary 
phase (Fig. 1) than did patients with a worse 13C-MBT readout value (Fig. 2).
Dixon MR measurements compared to 13C-MBT readout. Considering all examinations, a simple 
linear regression model showed that both rrT1_in and rrT1_W (r = 0.711; r = 0.751; p < 0.001) are strong lin-
ear predictors of log-transformed 13C-MBT readouts (Table 2). When analyzing rrT1_in and rrT1_W data on a 
scatterplot of logarithmic values of 13C-MBT readout, both patterns showed strong similarities (Figs 3 and 4). 
A comparison of the correlation coefficients of rrT1_in and rrT1_W on 13C-MBT readouts reveals a significant 
difference (p = 0.0163).
Dixon MR measurements compared with group-specific 13C-MBT readout. In group 1 (nor-
mal liver function), the mean 13C-MBT readout was 396.85 ± 60.25 µg/kg/h, rrT1_in was 60.99 ± 7.66 and 
rrT1_W was 63.14 ± 6.72. The group with intermediate liver function (group 2) had a mean 13C-MBT readout of 
217.53 ± 50.26 µg/kg/h, rrT1_in of 52.21 ± 10.87 and rrT1_W of 54.04 ± 10.86. In group 3, the observed mean 








age [years] 61.85 ± 9.54 61.00 ± 11.64 63.03 ± 9.83 60.74 ± 6.92
male 62 (78.48%) 8 (40.0%) 33 (91.67%) 21 (91.30%)
female 17 (21.52%) 12 (60.0%) 3 (8.33%) 2 (8.70%)
height [cm] 173.19 ± 7.65 168.70 ± 9.10 174.86 ± 7.36 174.48 ± 5.03
weight [kg] 86.08 ± 16.06 78.70 ± 21.64 89.08 ± 13.14 87.78 ± 12.98
rrT1_in [%] 50.05 ± 13.55 60.99 ± 7.66 52.21 ± 10.87 37.16 ± 11.06
rrT1_W [%] 51.75 ± 13.66 63.14 ± 6.72 54.04 ± 10.86 38.27 ± 10.87
13C-MBT [µg/kg/h] 227.38 ± 122.24 396.85 ± 60.25 217.53 ± 50.26 95.44 ± 36.75
Table 1. Patient characteristics.The different 13C-MBT readout groups did not differ significantly from each 
other with respect to age, height or weight. However, group 1 (>315.0 [µg/kg/h]) was significantly shorter 
(p < 0.05) and lighter (p < 0.05) than group 2 (140.0–315.0 [µg/kg/h]) and group 3 (<140.0 [µg/kg/h]). 
All groups were significantly different with respect to rrT1_in and rrT1_W (p < 0.001). Values indicate 
means ± standard deviation. rrT1_in: reduction rate of T1 relaxation time using in-phase T1 mapping. rrT1_W: 
reduction rate of T1 relaxation time using water-only T1 mapping. 13C-MBT: liver function capacity estimated 
by breath analysis of 13C-labeled methacetin metabolism.
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13C-MBT readout was 95.44 ± 36.75 µg/kg/h, whereas the mean rrT1_in was 37.16 ± 11.06 and the mean rrT1_W 
was 38.27 ± 10.87 (Table 1).
All pairwise comparisons between groups 1 to 3 were statistically significant (p < 0.01) for both rrT1_in and 
rrT1_W (Fig. 5).
Discussion
Nonalcoholic fatty liver disease (NAFLD) has been established as a serious disease for several decades. NAFLD 
is known to be accompanied by asymptomatic elevation of liver enzymes and nonalcoholic hypertransamina-
semia19. Affected patients may experience a high risk for establishing insulin resistance, obesity, liver fibrosis, 
liver cirrhosis and hepatocellular carcinoma (HCC)20. The majority of patients with NAFLD have simple stea-
tosis, whereas up to 30% suffer from non-alcoholic steatohepatitis (NASH) accompanied by an increasing risk 
of progression to end-stage liver disease21. The histological criterion for diagnosing NAFLD requires that 5% of 
hepatocytes contain intracellular fat22. As NAFLD-caused liver fibrotic cells contain a higher lipid content than 
do non-NAFLD-caused liver fibrotic cells, MR imaging might vary between the two.
Recently, gadoxetic acid-supported MR imaging was used to display liver function, as the intracellular uptake 
of Gd-EOB-DTPA and the consecutive shortening of the T1 relaxation time depend on hepatocyte function. 
Therefore, assessing imaging-based liver function when fat deposition in the liver varies is of clinical importance, 
Figure 1. Color-coded T1 maps and T1-weighted sequence based on a 3D variable flip angle sequence of the 
liver parenchyma of a 47-year-old female patient with regular liver capacity (13C-MBT = 327 [µg/kg/h]). T1-
weighted VIBE sequence with frequency-selective fat saturation (A,B) and T1 maps (C–F) were generated in 
native (A,C,E) and hepatobiliary phase (B,D,F). Respective T1-shortening effect can be observed as an increase 
in signal intensity of the liver in a T1-weighted VIBE sequence (B) and as a dark-blue region in color-coded 
T1 maps, representing a decreased relaxation time (D,F). Fat-water separation was applied according to the 
Dixon technique for the T1 maps (E,F). When applying fat suppression on T1 maps (E,F), the overall registered 
relaxation time increased compared with that of T1 maps without fat separation (C,D). The background of the 
T1 maps was manually set to black to facilitate color visualization.
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as intrahepatic fat may either affect the measurement of hepatocyte-specific contrast agent uptake or affect the 
shortening of the T1 relaxation time itself due to its paramagnetic properties7. T1 relaxation indicates the rate of 
longitudinal relaxation, which depends on tissue type and can be altered by injection of paramagnetic materials. 
In common T1 mapping approaches, only one T1 value is considered per reconstructed voxel. This assumption 
Figure 2. Color-coded T1 maps and T1-weighted sequence based on a 3D variable flip angle sequence of the 
liver parenchyma of a 63-year-old male patient with severe reduced liver capacity (13C-MBT = 135 [µg/kg/h]). 
T1-weighted VIBE sequence with frequency selective fat saturation (A,B) and T1 maps (C–F) were generated in 
native (A,C,E) and hepatobiliary phase (B,D,F). RespectiveT1-shortening effect can be observed as an increase 
in signal intensity of the liver in a T1-weighted VIBE sequence (B) and as a dark-blue region in color-coded 
T1 maps, representing a decreased relaxation time (D,F). Fat-water separation was applied according to the 
Dixon technique for the T1 maps (E,F). When applying fat suppression on T1 maps (E,F), the overall registered 
relaxation time increased compared with that of T1 maps without fat separation (C,D). The background of the 
T1 maps was manually set to black to facilitate color visualization.
B (95%-CI) P - value r
Log(13C-MBT)
rrT1_in 0.015 (0.012; 0.019) <0.001 0.711
T1_inpost −0.001 (−0.002; −0.001) <0.001 0.556
rrT1_W 0.016 (0.013; 0.019) <0.001 0.751
T1_Wpost −0.001 (−0.002; −0.001) <0.001 0.557
Table 2. Simple linear regression models of rrT1_in and rrT1_W on 13C-MBT values. rrT1_in: reduction rate 
of T1 relaxation time using in-phase T1 mapping. rrT1_W: reduction rate of T1 relaxation time using water-
only T1 mapping. 13C-MBT: liver function capacity estimated by breath analysis of 13C-labeled methacetin 
metabolism. r: multiple correlation coefficient. B: linear regression coefficient. CI: confidence interval for B.
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may be violated in the presence of two different tissue types constituting two different compartments that contrib-
ute to the MR signal in a single voxel. In such a case, the determined value of T1 can be considered an effective T1 
with a value in between that of the two tissue types. By using Dixon water-fat separation, the signals from water 
and fat compartments are separated before T1 calculation.
As the quantification properties of most tissues are known (e.g., macromolecules, small organic molecules, 
bound water, free water, and mobile fatty acids), tissues’ relaxation properties can be assumed, and a crude pre-
diction of T1 and T2 relaxation values is possible23. The Dixon technique is a frequency-selective approach that 
achieves fat separation and quantification while processing the phase evolution differences of water and fat gen-
erated by different echo times (TEs). Therefore, in-phase and opposed-phase images of water and fat will be 
recorded, and water-only or fat-only images will be generated by an algorithm, respectively16.
As the Dixon method is a spectrally selective method and relaxation only affects the magnetization, inde-
pendently of the resonance frequency, T1 mapping and Dixon method can be combined. Consequently, the T1 
values of the separated species can be determined independently.
In almost all tissues, the detected T1 relaxation time per voxel is composed of the allocated T1 relaxation 
times of local fat and water protons; thus, the presence of intra-hepatic fat affects voxel evaluation. Voxels var-
ying in partial volume of fat and hepatic tissue may lead to errors in T1 maps, which assume a single T1 spe-
cies. Moreover, the hepatocyte-specific contrast agent Gd-EOB-DTPA is a nine-coordinate complex in which 
the EOB-DTPA-ligand occupies eight binding sites at the metal center of Gd3+ and the ninth coordination site 
is meant to be occupied by a solvent water molecule11. Due to dipole-dipole interactions with the paramagnetic 
Figure 3. Correlation analysis of rrT1_in on logarithmic values of 13C-MBT readout (13C-MBT). Scatterplot of 
the reduction rate of T1 relaxation time in non-fat-saturated T1 maps (rrT1_in) in logarithmic values of 13C-MBT 
readouts.
Figure 4. Correlation analysis of rrT1_W on logarithmic values of 13C-MBT readout (13C-MBT). Scatterplot of 
the reduction rate of T1 relaxation time in fat-saturated water-only T1 maps (rrT1_W), in logarithmic values of 
13C-MBT readouts.
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contrast agent, the gadoxetic-supported T1 time of the water molecules will be shortened11, whereas respective 
T1 relaxation time of fatty acids may not or may only negligibly be affected.
Our analysis showed that Dixon-based water-only T1 maps correlate more strongly with the correspond-
ing determined 13C-MBT (r = 0.751, p < 0.001) values than in-phase T1 maps without fat saturation (r = 0.711, 
p < 0.001; Table 2). Therefore, the elimination of fat (water-only T1 maps) improves the informative value for 
evaluation of liver function.
Figure 5. Reduction rates of T1 relaxation time by 13C-MBT readouts in T1 maps without fat separation 
(rrT1_in; A) and water-only T1 maps with fat separation (T1_W; B). The difference in reduction rates of the T1 
relaxation time is statistically significant between the first and third groups in T1 maps without fat separation 
(A: p < 0.001) as well as in T1 maps with fat separation (B: p < 0.001). The difference is also statistically 
significant from that of the second group, either in T1 maps without fat separation (A: p = 0.003) or water-only 
T1 maps (B: p = 0.002). Group two differs significantly from group three in T1 maps without fat separation 
(A: p < 0.001) and T1 maps with fat separation (B: p < 0.001). group 1 13C-MBT >315 [µg/kg/h]: normal liver 
capacity. group 2 13C-MBT 315-140 [µg/kg/h]: intermediate liver capacity. group 3 13C-MBT <140 [µg/kg/h]: 
severe impaired liver capacity. Data are shown as the mean T1 reduction rates ± standard deviation. **p < 0.01, 
***p < 0.001.
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Similarly to the findings of Katsube et al.6, we could show that T1 mapping is a reliable tool for liver function 
estimation3,8,24,25. As the T1 relaxation time per voxel is affected by its fat and water composition and corre-
sponding hepatic contrast agent uptake and T1 shortening, we assumed that diagnostic precision will change on 
water-only T1 maps relative to in-phase T1 maps.
The literature suggests that little is known about the effect of fat-suppressed T1 maps relative to that of non- 
fat suppressed maps. Papakonstantinou et al.26 compared fat-suppressed and conventional R2 relaxometry on 
hepatic, pancreatic, spleen and vertebral bone marrow tissue. The authors observed that fat suppression applied 
in a standard Carr-Purcell-Meiboom-Gill sequence improves the quantification of iron in lipid-rich tissues. Here, 
we used a different MRI sequence with water-only (fat-suppressed) and in-phase (not fat-suppressed) T1 relax-
ometry. However, similarly to Papakonstantinou et al., we were able to show that MRI-based estimation of liver 
function improves using a water-only sequence on T1 relaxometry maps. Several studies have examined either 
water-only or in-phase sequences on T1 maps to evaluate tissues functional status27–30. However, no group has 
compared the evaluative information quality of water-only T1 maps with that of in-phase T1 maps.
Nevertheless, our study has several restrictions: It was carried out with a small number of patients in only one 
study site and only one radiologist was involved in ROI placement. Due to the study’s retrospective design, we 
lacked histopathologic controls. Further prospective studies are required to identify patients’ fat fraction, which 
would enable the recruitment of a subset of patients suffering from non-alcoholic fatty liver disease.
In conclusion, our study showed that water-only T1 maps represent liver function, assessed by 13C-MBT, more 
accurately than do T1 maps without fat separation.
Material and Methods
Patients. The local institutional review board approval of the University Hospital Regensburg was obtained 
for this retrospective study. The study was performed in accordance with the relevant guidelines and regulations 
and written informed consent was obtained from all participating patients. The current retrospective analysis is 
based in parts on a previously published study of our group8.
Seventy-nine patients (62 men, 17 women; mean age 61.85 ± 9.54years) underwent both 13C-MBT (LiMAx® 
test) and gadoxetic acid-supported MRI at 3 T of the liver parenchyma with 3D variable flip angle T1 mapping 
combined with Dixon water-fat separation. Only patients without 13C-methacetin intolerance, a known reaction 
to gadoxetic acid or renal failure could be evaluated.
The underlying diseases for the MR examination and the 13C-MBT are summarized in Table 3.
13C-Methacetin breath test (13C-MBT). Within 24 hours before or after the MRI examination, 13C-MBT 
was performed if patients fasted for at least 3 hours. Before 2 mg/kg body weight of 13C-methacetin could be 
administered intravenously, the baseline of normally exhaled 12CO2 was recorded over a period of 10 minutes. 
Finally, the change in the 13CO2/12CO2 ratio was measured over a period of 60 minutes and the amount of pro-
duced 13CO2 was determined. Based on the resulting 13C-MBT value[µg/kg/h], the patients could be divided into 
3 different groups similar to our previous published study (normal liver function, >315; moderate liver function, 
315-140; strongly reduced liver function, <140)8,13,31.
MR imaging. A 3 T MANGETOM Skyra (Siemens Healthcare, Erlangen, Germany) with a combination 
of spine (32-channel spine matrix coil) and body array (18-channel body matrix coil) coil elements was used 
to generate T1 maps using T1- weighted images (VIBE-sequences) with Dixon water-fat separation (TE1/
TE2: 2.46/3.69 ms; TR: 5.79 ms, reconstructed voxel size, 1.25 × 1.25 × 3.00 mm³; measured voxel size, 
3.57 × 2.5 × 4.82 mm³; acquisition time, 17 sec) and multiple flip angles (1°, 7°, and 14°). Respective maps were 




















Table 3. Underlying diseases and reasons for MRI examination. The medical cases examined via MRI and  
13C-MBT, divided according to their diseases.
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the T1 mapping acquisitions were preceded by an additional B1 mapping sequence. These data were used in the 
inline T1 calculation to address B1 inhomogeneities that affect the determined T1 values. The patients received 
a body-weight-adapted gadoxetic acid dose (0.025 mmol/kg body weight) administered via bolus injection (flow 
rate, 1 mL/s) and 0.9% sodium chloride (20 mL) for flushing.
Image analysis. An operator-defined region of interest (ROI) measurement was used to receive respective 
T1 relaxation times from maps in native and hepatobiliary phase. Here, 4 ROIs were manually placed with care at 
identical locations in respective maps excluding imaging artifacts, liver lesions or visible blood vessels. ROIs were 
circular and ranged from 0.8 to 4.4 cm² in size. The radiologists were blinded to the clinical, hematological and 
other radiological information to avoid measurement bias. The reduction rate of the T1 relaxation time (rrT1) 










T1pre and T1post represent the T1 times before and after gadoxetic acid administration, respectively8.
Statistical analysis. The different 13C-MBT readout groups were tested as non-parametric independent 
samples by the Mann-Whitney-U test. Gadoxetic acid-supported T1 mapping measurements (T1pre, T1post) 
and rrT1 (rrT1_in; rrT1_W) were tested in respective regression models to evaluate predictive power. Correlation 
coefficients were compared using the method proposed by Steiger. Statistical analyses were carried out using R 
(version 3.3.3., The R Foundation for Statistical Computing) and IBM SPSS Statistics (version 23, IL, USA) with 
a two-sided significance level of 0.058.
Data Availability
All data that support the findings of this study are provided in the manuscript. Raw data used in this work are 
available on reasonable request.
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